000 | 01498 a2200445 4500 | ||
---|---|---|---|
005 | 20250511224449.0 | ||
264 | 0 | _c19900315 | |
008 | 199003s 0 0 eng d | ||
022 | _a0162-0886 | ||
024 | 7 |
_a10.1093/clinids/12.1.31 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPorath, A | |
245 | 0 | 0 |
_aEffectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease. _h[electronic resource] |
260 |
_bReviews of infectious diseases _c |
||
300 |
_a31-40 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntibodies, Viral _xanalysis |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 | _aCosts and Cost Analysis |
650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
650 | 0 | 4 |
_aCytomegalovirus Infections _xcongenital |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunization _xeconomics |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPregnancy Complications, Infectious _xepidemiology |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aProbability |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aVaccines, Attenuated |
650 | 0 | 4 | _aViral Vaccines |
700 | 1 | _aMcNutt, R A | |
700 | 1 | _aSmiley, L M | |
700 | 1 | _aWeigle, K A | |
773 | 0 |
_tReviews of infectious diseases _gvol. 12 _gno. 1 _gp. 31-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/clinids/12.1.31 _zAvailable from publisher's website |
999 |
_c2160160 _d2160160 |